It often starts with a single line in a marketing draft: a promise to “heal,” “cure,” or bring fast relief. To a brand team, it feels like persuasive copywriting. But when evaluated against BPOM supplement claim guidelines, that single phrase changes everything. Suddenly, a product designed as a daily health supplement crosses a regulatory threshold and risks being reclassified as a drug or natural medicine.
Navigating this line is a critical hurdle for business leaders and technical teams alike. Whether you are an overseas brand owner planning market entry, a local importer scaling a wellness portfolio, or a regulatory affairs manager auditing marketing collateral, understanding these boundaries saves months of approval delays. Once a product drifts into the pharmaceutical regime under BPOM Regulation No. 32 of 2022 (PerBPOM 32/2022), the entire go-to-market strategy shifts, forcing you into a far more demanding registration dossier, higher official fees, and stricter manufacturing standards.
Crucially, BPOM (Badan Pengawas Obat dan Makanan) looks at more than just the explicit claims printed on your packaging. Reclassification is often triggered by the total presentation of the product. In fact, we have seen products with completely clean text still get flagged as pharmaceutical-grade pain relievers simply because of the imagery and artwork on the box.
This guide breaks down the practical boundaries of supplement messaging in Indonesia, giving brand strategists, compliance specialists, and distributor teams a single framework to audit packaging, websites, and sales decks before going to print.
What do the BPOM supplement claim guidelines allow a supplement to say?
Under BPOM Regulation No. 32 of 2022, a health supplement may carry benefit claims, including general/nutrient claims, functional claims, and disease-risk-reduction claims, and is not intended to make claims regarding the prevention or treatment of a disease. Allowed wording comes from BPOM Regulation No. 19 of 2022, not from the brand owner.
BPOM Regulation No. 19 of 2022 on Guidelines for Health Supplement Claims sets out three things: the principles of claims, the types of benefit claims, the supporting documents, including examples of well-documented claims. A claim is only as strong as the documents behind it.
Labelling adds a second layer. BPOM Regulation No. 10 of 2024 governs the labelling of natural medicine, quasi-drugs and supplements, and labelling must not mislead. A statement that is technically accurate can still mislead through context, which is why total presentation matters.
Claim limits also vary by ingredient type. As our probiotic supplement registration guide explains, claims beyond digestive health support depend on strain-level clinical evidence, so the same product concept can carry very different wording depending on its evidence.
The legal basis at a glance
| Instrument | Issuing body | What it settles |
|---|---|---|
| BPOM Regulation No. 32 of 2022 | BPOM | Registration criteria for health supplements. Supplements are not intended for claims of preventing or treating a disease. |
| BPOM Regulation No. 19 of 2022 | BPOM | Guidelines for health supplement claims: principles, claim types, supporting documents, examples of well-documented claims. |
| BPOM Regulation No. 10 of 2024 | BPOM | Labelling of natural medicine, quasi-drugs and supplements; labelling must not mislead. |
| BPOM Regulation No. 34 of 2022 | BPOM | Supervision of advertising for natural medicine, quasi-drugs and supplements. |
| Government Regulation No. 15 of 2026 (PP 15/2026) | President of the Republic of Indonesia | BPOM non-tax state revenue tariffs, with ceilings per item. |
Where the line sits: language that moves a product into the drug regime
Think of claim language as a direction of travel. Language describing a nutrient’s role in the body points toward supplement territory. Language promising an outcome against a named disease points toward medicine. The table shows how we read common directions in practice.
| Language direction | Type of wording | Our reading in practice |
|---|---|---|
| Nutritional or body-function role | Describes what a nutrient does in the body | Benefit-claim territory, if documented under BPOM Regulation 19/2022 |
| Disease-risk reduction | Links an ingredient to a lower risk of a condition | Benefit-claim territory, with its own supporting documents |
| Named disease as the purpose | A product described as “for” a specific disease | Drug-like. High reclassification risk |
| Cure, heal or treat verbs | Promises that a condition is resolved | Direct medical effect. Crosses the line |
| Pharmaceutical-type effect | Drug comparisons, medication replacement, symptom relief | Pharmaceutical-type claim. Crosses the line |
| Imagery with drug cues | Pain graphics, medical symbols, clinical styling | Read as a claim even when the text is silent |
The table is a screening aid, not an approval. Whether a specific sentence is acceptable depends on the documented evidence and on BPOM Regulation 19/2022, so final wording should be confirmed with a regulatory reviewer before it reaches a printer.
Words and signals that should trigger escalation
- A disease or condition name used as the purpose of the product.
- Verbs such as cure, heal, treat, therapy or remedy.
- Comparisons to a drug, or suggestions to replace medication.
- Symptom-relief language, including pain relief.
- Testimonials that imply a condition was treated.
- Medical symbols, body-part pain graphics or clinical styling.
Why artwork counts as part of the claim
In our experience, a product whose text made no claim was still read as a pain-relief product from its artwork. The wording was clean; the pack was not. Reviewers read the pack as a whole, so colours, icons and imagery face the same scrutiny as sentences.
The same logic extends beyond the label. Websites, marketplace listings and distributor decks often carry stronger language than the pack. BPOM Regulation No. 34 of 2022 covers advertising supervision for supplements, as BPOM has explained publicly, so one standard must apply across every channel.
Sensitive categories raise the stakes. Our guide to pregnancy supplement registration in Indonesia shows how BPOM assesses a file for that category, and it is a useful companion read on claim discipline.
What happens to Health Supplement Registration Indonesia when a product is reclassified
A supplement judged on its claims as natural medicine or a drug leaves the Health Supplement Registration Indonesia pathway. It follows a different dossier, fee item and manufacturing standard, so the registration plan and budget must be rebuilt, not adjusted.
The fee moves too. BPOM tariffs are set by Government Regulation No. 15 of 2026 (PP 15/2026), issued by the President of Indonesia, with ceilings per item. A reclassified product sits under a different item, so the earlier budget no longer applies.
Manufacturing expectations change as well. CPOTB (Cara Pembuatan Obat Tradisional yang Baik) means Good Manufacturing Practice for traditional medicine, and CPOB (Cara Pembuatan Obat yang Baik) means Good Manufacturing Practice for drugs. A facility ready for one may not be ready for the other.
Technical evidence expectations also shift. Supplement dossiers already demand careful data, as our guide to PerBPOM 6/2025 stability testing for health supplements shows. In our experience, a drug pathway asks for more, so a late reclassification costs far more than a relabel.
For that reason, the cheapest moment to settle the category is before artwork is commissioned. A short review by our Health Supplements Registration team can test the product concept against the claim line first.
Why claim wording is a commercial risk, not only a regulatory one
A BPOM press release dated 8 December 2023 reported that, between September 2022 and October 2023, BPOM blocked 61,784 sales links for illegal traditional medicine and supplements, including products containing drug chemicals known as BKO (Bahan Kimia Obat).
The same release lists sanctions from written warnings and withdrawal to cancellation of the marketing authorisation number, known as NIE (Nomor Izin Edar). It also cites Article 435 of Law No. 17 of 2023 on Health.
That article carries up to 12 years of imprisonment or a fine of up to Rp5 billion for producing or distributing pharmaceutical preparations that fail safety, efficacy and quality standards. These figures describe the enforcement environment, not the penalty for any single claim.
In our experience, claim language is also one of the first things a reviewer, distributor or marketplace notices. A mismatch between registered category and presentation therefore surfaces early, usually when changing it is most expensive.
One list for your pack, website and distributor deck
The closing decision is simple to state: review the pack, the website and the distributor deck against one list. Any word that names a disease, a cure or a drug-like effect comes out before the label is printed.
- Collect every customer-facing item: pack, insert, website, marketplace listing, social posts and distributor deck.
- Mark each word, image or symbol that names a disease, a cure or a drug-like effect.
- Check every remaining claim against the documented support held for it.
- Confirm that wording and imagery on the pack tell the same story.
- Send the marked set for regulatory review before anything is printed.
Steps one to four organise the work. Step five carries the judgement, because the final decision on any word belongs with a regulatory reviewer who can read it against BPOM Regulation 19/2022 and the evidence held.
Keep the claim inside the line and the launch on track
Claim language rarely fails because a brand wants to mislead. It fails because wording, artwork, and distributor copy drift apart over months. The encouraging part is that this is one of the most fixable risks in Health Supplement Registration Indonesia, since the fix costs little before printing.
Product Registration Indonesia supports supplement brands from category decision to marketing authorisation. To have your pack, website, and distributor materials reviewed against the claim line, fill out our contact form below to connect with our Health Supplements Registration team and avoid compliance risks before going to print.
